Better prostate cancer care for men living with HIV
Optimizing Treatment of Prostate Cancer in Men living with HIV
This project compares treatment options to find safer, more effective prostate cancer care for men living with HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11131218 on NIH RePORTER |
What this research studies
I am a man living with HIV facing localized prostate cancer, and researchers will look at how different treatments like surgery, radiation, or active surveillance affect people like me. They will compare cancer control, treatment side effects, quality of life, and survival using medical records and patient-reported outcomes. The team will account for HIV-related factors that might change cancer behavior or treatment tolerance. The goal is to help patients and doctors choose treatments that balance benefits and harms.
Who could benefit from this research
Good fit: Men living with HIV who have clinically localized (early-stage) prostate cancer and are considering treatment options are the ideal candidates.
Not a fit: People without HIV or men with advanced/metastatic prostate cancer are unlikely to be helped directly by findings focused on localized disease.
Why it matters
Potential benefit: If successful, this work could give men with HIV clearer guidance on choosing prostate cancer treatments that lower side effects and improve survival and quality of life.
How similar studies have performed: Few or no clinical trials have focused specifically on prostate cancer care in men with HIV, so this approach is relatively novel and addresses a major evidence gap.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sigel, Keith Magnus — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sigel, Keith Magnus
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.